Aarey Drugs & Pharmaceuticals Ltd Share Price
Last Updated Date: 17 Sept 2026
₹101.32
+0.45 (+0.45%)
As of 18 Sept 2026, Aarey Drugs & Pharmaceuticals Ltd share price is ₹101.32. The stock opened at ₹101.32 and had closed at ₹100.87 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹50.40 and a high of ₹101.13. In terms of performance, Aarey Drugs & Pharmaceuticals Ltd share price has increased by 39.05% over the past six months and has increased by 33.90% over the last year.
AAREYDRUGS Stock Price Chart
Aarey Drugs & Pharmaceuticals Ltd Overview
Market cap₹311 Crs
Volume32,021
Prev. Close₹100.87
Year range₹50.40 - ₹101.13
ISININE198H01019
About AAREYDRUGS
Aarey Drugs & Pharmaceuticals in the manufacturing and trading of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and specialty chemi'cals.
Aarey Drugs & Pharmaceuticals Ltd Historical Performance
1 Month Return19.81%
6 Month Return60.54%
3 Year Return107.30%
3 Month Return29.95%
1 Year Return39.32%
5 Year Return178.26%
Aarey Drugs & Pharmaceuticals Ltd Fundamentals
ROCE(TTM)5.20%
P/E Ratio (TTM)74.72
P/B Ratio1.87
Debt to Equity0.33
ROE2.64%
EPS (TTM)1.35
Dividend Yield0.00%
Book Value53.90
Profit Margin1.01%
Operating Margin0.86%
Aarey Drugs & Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 478.37 | 483.75 | 402.58 | 421.69 | 495.43 |
| EBITDA | 13.26 | 12.70 | 11.42 | 10.46 | 14.02 |
| Net Profit | 3.97 | 4.02 | 4.68 | 3.78 | 6.54 |
| EPS | 1.39 | 1.43 | 1.84 | 1.49 | 2.72 |
Aarey Drugs & Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 96.37 |
| Resistance 1 (R1) | 103.25 |
| Pivot Point | 98.75 |
AAREYDRUGS Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Mihir R Ghatalia | Chairman & Managing Director |
| Nimit R Ghatalia | E D & Wholetime Directorector |
| BINA RAJESH GHATALIA | Non Executive Independent Director |
Aarey Drugs & Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aarey Drugs & Pharmaceuticals Ltd today is ₹101.32 on NSE and ₹101.32 on BSE.
- The 52-week high of Aarey Drugs & Pharmaceuticals Ltd is ₹101.13, while the 52-week low is ₹50.40.
- The current market capitalisation of Aarey Drugs & Pharmaceuticals Ltd is approximately ₹311 crore.
- The P/E (Price-to-Earnings) ratio of Aarey Drugs & Pharmaceuticals Ltd is 74.72. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aarey Drugs & Pharmaceuticals Ltd is 1.87. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Aarey Drugs & Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for AAREYDRUGS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Aarey Drugs & Pharmaceuticals Ltd has delivered a return of approximately 107.30%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aarey Drugs & Pharmaceuticals Ltd comprises different categories of shareholders. As of Aug 2026, the shareholding is approximately 42.79% promoters, 4.41% FIIs, 1.49% DIIs, and 38.26% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
